|
NRIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.540800E-03 |
| Normal-vs-Stage3 |
1.99840144432528E-15 |
| Normal-vs-Stage4 |
1.71580000207783E-08 |
| Stage1-vs-Stage2 |
1.015420E-01 |
| Stage1-vs-Stage3 |
3.752800E-01 |
| Stage1-vs-Stage4 |
7.512600E-01 |
| Stage2-vs-Stage3 |
3.131800E-01 |
| Stage2-vs-Stage4 |
2.560000E-01 |
| Stage3-vs-Stage4 |
7.341000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.918190E-03 |
| Normal-vs-Asian |
3.73320000024435E-07 |
| Caucasian-vs-AfricanAmerican |
7.042800E-01 |
| Caucasian-vs-Asian |
1.152010E-01 |
| AfricanAmerican-vs-Asian |
3.288400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.88657986402541E-15 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.301220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.11059999980046E-08 |
| Normal-vs-Age(81-100Yrs) |
4.201300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.232400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.681900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.267650E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.306000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.319830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.211400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.677400E-01 |
| Classical-VS-Follicular |
1.0278999873492E-11 |
| Classical-VS-Other |
2.610000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.36019999999559E-05 |
| Tall-VS-Other |
2.044000E-01 |
| Tall-VS-Normal |
8.60940000402266E-08 |
| Follicular-VS-Other |
3.010600E-01 |
| Follicular-VS-Normal |
1.140370E-02 |
| Other-VS-Normal |
8.841600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.77076189453874E-15 |
| Normal-vs-N1 |
5.65349989045671E-10 |
| N0-vs-N1 |
2.728800E-01 |
|
|
